Toxicity of isocycloseram, an isoxazoline insecticide, against laboratory and field-collected German cockroaches (Blattodea: Ectobiidae)

• Published in: Journal of economic entomology Vol. 117; no. 3; pp. 1086 - 1094
• Main Authors: Lee, Shao-Hung, So, John, Kund, Gregory S., Lum, Jun-Yin, Trinh, Ethan, Ta, Emily L., Chungsawat, Rattanan, Choe, Dong-Hwan, Cox, David L., Rust, Michael K., Lee, Chow-Yang
• Format: Journal Article
• Language: English
• Published: England Entomological Society of America 16-04-2024
• Subjects: Animals; Blattellidae - drug effects; Female; HOUSEHOLD AND STRUCTURAL INSECTS; Insect Control; insecticide resistance; Insecticides; Isoxazoles; Male; piperonyl butoxide; Plinazolin; secondary transfer; Plinazolin; insecticide resistance; piperonyl butoxide; secondary transfer
• ISSN: 0022-0493; 1938-291X
• DOI: 10.1093/jee/toae079

Isocycloseram is a new insecticide in the isoxazoline class that targets insect GABA-gated chloride channels. In this study, we evaluated a cockroach gel bait formulation containing 1% isocycloseram against a susceptible strain (UCR) and 5 field-collected strains (WM, RG386, Ryan, CDR, and SY) of the German cockroach, Blattella germanica (L.) (Blattodea: Ectobiidae), and compared it with several commercial insecticide baits in the laboratory. Using the Ebeling choice box method, we also tested a residual deposit of an SC formulation of isocycloseram against the UCR, RG386, and Ryan strains. The isocycloseram bait was among the fastest-performing treatments against adult males (mean survival time: 0.9–2.7 days) and mixed stages and sexes (mean survival time: 1.4–5.4 days) across all strains. Secondary transfer effects of the bait were demonstrated in the UCR strain by exposing new adult males to individuals killed by direct bait treatment. Physiological resistance was not detected in the WM, CDR, and RG386 strains with topical treatment of a diagnostic dose (3× LD95) of isocycloseram developed using the UCR strain. However, topical assays revealed resistance ratios (RR50) of 1.6 and 3.0× in the Ryan and SY strains, respectively. The performance of a 0.05% isocycloseram residual application against the Ryan strain was improved with the addition of piperonyl butoxide.